Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 13/20 | 0.45 |
| ▸ | KMO | O15229 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4250516 | 0.89 | REN (0.47) | RENKMOSLC22A12 | |
| SCHEMBL4253933 | 0.82 | REN (0.45) | RENKMOSLC22A12ADORA2AADORA2B | |
| SCHEMBL4249553 | 0.78 | REN (0.45) | RENKMONR3C1SLC22A12ADORA2A | |
| SCHEMBL4257515 | 0.77 | REN (0.52) | RENKMOSLC22A12 | |
| SCHEMBL13448565 | 0.76 | REN (0.45) | RENKMONR3C1SLC22A12ADORA2A | |
| SCHEMBL78153 | 0.72 | REN (0.55) | RENKMOSLC22A12ADORA2AADORA2B | |
| SCHEMBL2807350 | 0.71 | REN (0.48) | RENKMONR3C1SLC22A12ALDH1A1 | |
| SCHEMBL91359 | 0.71 | REN (0.46) | RENKMONR3C1SLC22A12ADORA2A | |
| SCHEMBL13131423 | 0.71 | ADORA2A (0.44) | RENKMOSLC22A12ADORA2AADORA2B | |
| SCHEMBL14144408 | 0.70 | REN (0.47) | RENKMOSLC22A12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090088576-A1 | Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-02 | — | — | US | disclosed |
| US-20090088576-A1 | Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-02 | — | — | US | disclosed |
| US-20090088576-A1 | Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-02 | — | — | US | disclosed |
| EP-1979323-A1 | PROCESS FOR THE STEREOSELECTIVE PREPARATION OF ALCOHOLS FROM ALPHA, BETA-INSATURATED COMPOUNDS | Speedel Experimenta AG (CH) | 2008-10-15 | — | — | EP | disclosed |
| WO-2008077917-A1 | PROCESS FOR PREPARING (R OR S)-2-ALKYL-3-HETEROCYCLYL-1-PROPANOLS | NOVARTIS AG (CH) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008077917-A1 | PROCESS FOR PREPARING (R OR S)-2-ALKYL-3-HETEROCYCLYL-1-PROPANOLS | NOVARTIS AG (CH) | 2008-07-03 | — | — | WO | disclosed |
| EP-1939182-A1 | Process for the preparation of (R or S)-2-Alkyl-3-heterocyclyl-1-propanols | Speedel Experimenta AG (CH) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007085651-A1 | PROCESS FOR THE STEREOSELECTIVE PREPARATION OF ALCOHOLS FROM ALPHA, BETA- INSATURATED COMPOUNDS | SPEEDEL EXPERIMENTA AG (CH) | 2007-08-02 | — | — | WO | disclosed |
| WO-2007085651-A1 | PROCESS FOR THE STEREOSELECTIVE PREPARATION OF ALCOHOLS FROM ALPHA, BETA- INSATURATED COMPOUNDS | SPEEDEL EXPERIMENTA AG (CH) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088576-A1 | Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds | ADH1C, ADH1A, EBP | REN 219/4885KMO 2953/4885NR3C1 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.